Doctor profile · Federal record
Dr. Ryan Kendle, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Santa Barbara, CA
- NPI 1861719551
- Accepts Medicare
- 16 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
540 W Pueblo St
Santa Barbara, CA 93105
(805) 879-0670 - Additional location
-
4150 V St, #1110
Sacramento, CA 958171460
(916) 734-7080 - Mailing address
-
Po Box 62106
Santa Barbara, CA 931602106
Credentials & registration
- NPI registered
- April 2010 — 16 yrs on file
- Profile last updated
- November 6, 2018
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- California #A119332
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1861719551. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
9,546
Distinct HCPCS
10
Medicare allowed
$169,586
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1453 |
Injection, fosaprepitant, 1 mg | 4,801 | 12 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 2,160 | 16 | $23 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 772 | 23 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 380 | 13 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 273 | 127 | $137 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 178 | 46 | $150 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 120 | 89 | $97 | |
96375 |
Injection of additional new drug or substance into vein | 118 | 23 | $17 | |
96372 |
Injection of drug or substance under skin or into muscle | 116 | 33 | $15 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 89 | 54 | $191 |
In context: peer comparison
Among 6 peers in this city , average services per provider: 914. This provider delivers 10× the peer median.Open Payments
Industry payments received
All-time total
$1,117
Transactions
41
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| EMD Serono, Inc. | 12 | $162.23 | |
| AstraZeneca Pharmaceuticals LP | 7 | $151.66 | |
| Novartis Pharmaceuticals Corporation | 6 | $146.66 | |
| Monteris Medical Corporation | 1 | $117.15 | |
| Astellas Pharma US Inc | 1 | $95.46 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $88.88 | |
| Adaptive Biotechnologies Corporation | 2 | $61.37 | |
| Janssen Biotech, Inc. | 3 | $52.18 | |
| ABBVIE INC. | 2 | $34.91 | |
| Apellis Pharmaceuticals, Inc. | 1 | $30.29 | |
| Incyte Corporation | 1 | $28.94 | |
| Celgene Corporation | 1 | $25.76 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24.27 | |
| Lilly USA, LLC | 1 | $24.18 | |
| PFIZER INC. | 1 | $22.96 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
135
Patients
0
Total drug cost
$191,207
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 29 | 0 | $544 |
| Eliquis (Apixaban) | Brand | 26 | 0 | $17,132 |
| Levothyroxine Sodium | Generic | 23 | 0 | $253 |
| Ondansetron Odt (Ondansetron) | Brand | 19 | 0 | $723 |
| Gabapentin | Generic | 13 | 0 | $108 |
| Tamoxifen Citrate | Generic | 13 | 0 | $374 |
| Ibrance (Palbociclib) | Brand | 12 | 0 | $172,073 |
Frequently asked questions
What is Dr. Ryan Kendle's medical specialty?
Dr. Ryan Kendle practices Hematology & Oncology Physician in Santa Barbara, CA.
Where does Dr. Ryan Kendle practice?
Dr. Ryan Kendle practices at 540 W Pueblo St, Santa Barbara, CA 93105. Office phone: 8058790670.
What is Dr. Ryan Kendle's NPI?
Dr. Ryan Kendle's National Provider Identifier (NPI) is 1861719551, issued by NPPES.
Does Dr. Ryan Kendle accept Medicare assignment?
Yes. Dr. Ryan Kendle accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ryan Kendle commonly perform?
Top Medicare-reported procedures in 2023: Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, denosumab, 1 mg (HCPCS J0897); Injection, dexamethasone sodium phosphate, 1 mg (HCPCS J1100). Source: CMS Medicare Physician & Other Practitioners file.